Marketplace All-in-One How Trump's proposed pharmaceutical tariffs could affect you
Aug 8, 2025
The discussion highlights Trump's proposed tariffs on pharmaceuticals and their potential impact on patients relying on these drugs. Experts worry about supply chain disruptions and accessibility issues. The conversation then shifts to intriguing tariffs on gold, revealing unexpected connections. Additionally, there's an exploration of the Democratic Republic of Congo's $50 million sports sponsorship deals, contrasting government enthusiasm with pressing national crises and drawing comparisons to Rwanda's strategies amid regional challenges.
AI Snips
Chapters
Transcript
Episode notes
Generics Manufacturers Can't Absorb Tariffs
- Mariana Socal and Marta Voshinska say generic makers have thin margins and can't easily absorb tariffs.
- That may push firms out of the U.S. market and cause shortages.
U.S. Relies On Imported Generics
- Samantha Fields notes 90% of U.S. prescriptions are generics and about 55% of pills are imported from India, Europe, and China.
- That global supply chain makes generics vulnerable to tariffs and price shocks.
Trump’s Drug Tariff Threat
- David Brancaccio reports Trump plans a small tariff now then possibly 250% later on imported prescription drugs.
- That policy could raise costs and disrupt import flows for U.S. patients.